| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |